Eagle's Eye View: Your Weekly CV Update From ACC.org Mechanical Circulatory Support in Infarct-Related Cardiogenic Shock, Anticoagulation Benefit in Device-Detected AFib, Semaglutide in HFpEF Patients
Sep 11, 2024
Discover the latest advancements in cardiovascular care! The discussion includes the use of temporary mechanical support for cardiogenic shock following a heart attack. Learn about the benefits of anticoagulation in patients with device-detected atrial fibrillation. The effectiveness of semaglutide in treating heart failure with mildly reduced or preserved ejection fraction is also highlighted. These insights aim to improve treatment strategies and patient outcomes.
Chapters
Transcript
Episode notes